Screener
Eligibility screening
Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Tha…
30 US sites in AR, CA, FL, GA +15
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.